FDA Inspection 1292954 — Emmanuel S. Ferrer II, M.D.
The FDA completed an inspection of Emmanuel S. Ferrer II, M.D. on November 18, 2025 in Saint Paul, MN. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- November 18, 2025
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Saint Paul, MN (United States)
Additional Details
Clinical BA/BE